Clínica Baviera, S.A. (BME:CBAV)

Market Cap	884.22M +40.2%
Revenue (ttm)	304.91M +14.7%
Net Income	42.06M +4.6%
EPS	2.63 +4.5%
Shares Out	16.02M
PE Ratio	21.02
Forward PE	n/a
Dividend	1.57 (2.84%)
Ex-Dividend Date	Jun 10, 2026

Volume	4,000
Open	55.40
Previous Close	55.40
Day's Range	54.60 - 55.40
52-Week Range	38.60 - 61.80
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínic...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,910
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 26, 2026

Data Sources Report a data error